Published in Vestn Otorinolaringol on January 01, 2005
Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens (1999) 1.27
Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension (1998) 1.17
Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens (1998) 1.06
Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol (Noisy-le-grand) (2006) 1.03
Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation. Hypertension (1995) 1.02
Digitalis-like and vasoconstrictor effects of endogenous digoxin-like factor(s) from the venom of Bufo marinus toad. Eur J Pharmacol (1993) 1.01
Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. Cardiovasc Res (1996) 1.01
Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta. Eur J Pharmacol (1995) 0.98
Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J Hypertens (1998) 0.86
Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction. Cardiovasc Res (1991) 0.84
Preavoidance hypercapnia and decreased hematocrit in micropigs. Physiol Behav (1996) 0.81
Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity. Am J Hypertens (1996) 0.81
Cytochemical properties of interphase chromatin condensed as a result of treatment with caffeine. Exp Cell Res (1979) 0.79
Endogenous digoxin-like factor in acute myocardial infarction. J Intern Med (1994) 0.78
Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus. Dokl Biol Sci (2006) 0.78
Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism. J Hypertens (2000) 0.77
Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats. Cardiovasc Res (1993) 0.76
Antiarrhythmic effect of antibodies to digoxin in acute myocardial ischemia in rats. Eur J Pharmacol (1989) 0.76
[Diagnosis of labyrinthine fistula in patients suffering from otitis media purulenta chronica with cholesteatoma: informative value of different methods]. Vestn Otorinolaringol (2008) 0.75
[The antimalarial action of Soviet artemisinine in Plasmodium berghei schizont infection in mice]. Med Parazitol (Mosk) (1989) 0.75
[The incidence of chronic purulent otitis media and the treatment of this pathology in Moscow]. Vestn Otorinolaringol (2010) 0.75
[Morphohistochemical study of fibrous obliteration of the tympanic cavity]. Vestn Otorinolaringol (1986) 0.75
[The prospects for the development of therapeutic and health-promoting tourism in Gorny Altai]. Vopr Kurortol Fizioter Lech Fiz Kult (2014) 0.75
[Subjective ear noise and hyperacusis. Treatment with fluctuating currents]. Vestn Otorinolaringol (2000) 0.75
[Differential atticoanthrotomy with type 1 tympanoplasty as the method of choice for the treatment of chronic perforating otitis media with expressed mucositis]. Vestn Otorinolaringol (2011) 0.75
[The experience of reconstructive surgery in patients after surgeries of the ear]. Vestn Otorinolaringol (1998) 0.75
[Accidental thymic involution in the growing body under the effect of different types of stressors]. Morfologiia (2006) 0.75
[The morphofunctional prerequisites for the development of exudative otitis media in the children presenting with chronic adenoiditis]. Vestn Otorinolaringol (2014) 0.75
[ANALGESIC EFFECT OF TROPALGIN ON THERMAL PAIN IN RATS WITH DIFFERENT PAIN THRESHOLDS]. Eksp Klin Farmakol (2015) 0.75
[Efficacy of conventional methods of treating otitis media purulenta chronica in patients with cholesteatoma and fistula of the labyrinth]. Vestn Otorinolaringol (2006) 0.75
[Diagnostics of endolymphatic hydrops]. Vestn Otorinolaringol (2013) 0.75
[A variant of monotherapy in vertigo and subjective noise in the ears]. Vestn Otorinolaringol (2002) 0.75
[The results of laser-assisted piston stapedoplasty in the patients with otosclerosis]. Vestn Otorinolaringol (2013) 0.75
[Characteristics of protein metabolism in labyrinthine tissue]. Vestn Otorinolaringol (1993) 0.75
[The retrospective clinical study of labyrinthine fistula associated with chronic suppurative otitis media and their treatment]. Vestn Otorinolaringol (2012) 0.75
[Fibrous dysplasia of the temporal bone]. Vestn Otorinolaringol (2005) 0.75
[The diagnostics and treatment of Minor's syndrome]. Vestn Otorinolaringol (2012) 0.75
[Computed tomography of the temporal bone for the diagnosis of facial nerve neurinoma]. Vestn Otorinolaringol (2010) 0.75
[R-factor from the natural strain of Salmonella derby carrying a DNA-polymerase gene]. Biokhimiia (1985) 0.75
[Treatment of subjective noise in the ear by impulse low-frequency electromagnetic field (preliminary results)]. Vestn Otorinolaringol (1998) 0.75
[Laser destruction of labyrinthine receptors as a treatment for benign paroxysmal postural vertigo and otolith symptoms]. Vestn Otorinolaringol (2007) 0.75
[Injury-dependent types of damage to ear structures]. Vestn Otorinolaringol (1998) 0.75
[The neurovascular conflict of the vestibulocochlear nerve. Etiology, diagnostics, the methods for the surgical and conservative treatment]. Vestn Otorinolaringol (2015) 0.75
[The search for new antiparasitic agents. 4. The study of the antimalarial activity of N-(halogen naphthyloxy)-2-hydroxy-3,5-dihalogen benzamides]. Med Parazitol (Mosk) (1992) 0.75
[Eye movement parameters in reading the sentences with syntactic ambiguity in Russian language]. Fiziol Cheloveka (2015) 0.75
[Diagnostic criteria and treatment strategies in traumatic injuries of the ear]. Vestn Otorinolaringol (2000) 0.75
[A course of early Meniere's disease]. Vestn Otorinolaringol (2007) 0.75
[The results of stapedoplasty with the use of an auricular autocartilage as a stapes bone prosthesis in the patients presenting with a mixed form of otosclerosis]. Vestn Otorinolaringol (2011) 0.75
[Sanation surgery for the treatment of chronic suppurative otitis media with cholesteatoma]. Vestn Otorinolaringol (2011) 0.75
[Modern views on diagnosis and therapeutic policy in non-purulent pathology of the internal ear]. Vestn Otorinolaringol (2007) 0.75
[Health and recreational localities in the republic of altai and prospects for the development of spa-and-resort services on their basis]. Vopr Kurortol Fizioter Lech Fiz Kult (2012) 0.75
[Impact of sound signals of high intensity on the acoustic analyzer]. Vestn Otorinolaringol (2006) 0.75
[Ganglioside protection of the erythrocyte membranes in myocardial ischemia]. Biull Eksp Biol Med (1992) 0.75
[Endogenous digoxin-like factor in myocardial infarction]. Klin Med (Mosk) (1996) 0.75
[Mathematical modeling of laser-induced selective destruction of labyrinthine vestibular receptors]. Vestn Otorinolaringol (2006) 0.75
[Strategies for the treatment of labyrinthine fistula in chronic purulent otitis media with cholesteatoma]. Vestn Otorinolaringol (1998) 0.75
[Use of mathematical models infrared spectroscopy serum in the differential diagnosis of ulcerative colitis and Crohn's disease in children]. Vestn Ross Akad Med Nauk (2013) 0.75
[Clinical aspects and treatment of sinus thrombosis including hyperbaric oxygenation]. Vestn Otorinolaringol (1986) 0.75
[Acoustic characteristics of resonance after cavity surgery on the ear and their usage in variants of reconstructive operations]. Vestn Otorinolaringol (2001) 0.75
[Combined drug therapy in patients with chronic otitis media and mucositis]. Vestn Otorinolaringol (2000) 0.75
[Therapeutic factors of lake Tagarskoye]. Vopr Kurortol Fizioter Lech Fiz Kult (2011) 0.75
[Plastic surgery of the tympanic membrane in its dry defects]. Vestn Otorinolaringol (1977) 0.75
[Treatment of patients with subjective noise in the ears]. Vestn Otorinolaringol (2008) 0.75
[Use of instrumental-programmable complex KES-01 in the diagnosis of the functional status of organism during rehabilitation treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2001) 0.75
[Forward-morphological criteria of ulcerative colitis relapse and continuous flow in children]. Vestn Ross Akad Med Nauk (2013) 0.75
[The sensitivity of a Plasmodium berghei strain resistant to artemisinin and other antimalarial preparations]. Med Parazitol (Mosk) (1991) 0.75
[The rehabilitation of patients with perilymphatic fistulae of the labyrinth]. Voen Med Zh (1999) 0.75
[Benign paroxysmal position vertigo and otolytic disorders]. Vestn Otorinolaringol (2007) 0.75
[Middle ear trauma]. Voen Med Zh (1999) 0.75
[Determination of the optimal method of treating experimental malaria using artemisinine]. Med Parazitol (Mosk) (1989) 0.75
[Electric stimulation of the muscles of the auditory tube as a method of controlling its opening]. Vestn Otorinolaringol (1986) 0.75